✦ LIBER ✦

Bcr-abl kinase inhibition as the basis of therapy for cml

✍ Scribed by Brian J. Druker; Moshe Talpaz; Debra Resta; Bin Peng; Eliasbeth Buchdunger; John Ford; Charles L. Sawyers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the Bcr-Abl tyrosine kinas

✍ Druker, Brian J 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Bcr-Abl inhibition as a modality of CML

✍ Elisabeth Buchdunger; Alex Matter; Brian J. Druker 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Allosteric inhibition enhances the effic

✍ Afsar Ali Mian, Anna Metodieva, Susanne Badura, Mamduh Khateb, Nili Ruimi, Youse 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 389 KB

Structural Basis for the Cytoskeletal As

✍ Oliver Hantschel; Silke Wiesner; Thomas Güttler; Cameron D. Mackereth; Lily L. R 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 943 KB

Inhibition of Bcr–Abl kinase activity by

✍ Huang, Mei; Dorsey, Jay F; Epling-Burnette, P K; Nimmanapalli, Ramadevi; Landows 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 449 KB

BCR-ABL insufficiency for the transforma

✍ G.T. Matioli 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 61 KB